Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Thompson

Showing results (61-70 of 160) with videos related to

Pageof 16
Sort By:
BMJ Open|September 21, 2023
Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UKAlexander Thompson, Ji-Hee Youn, Bruce Guthrie, et al.
Stem Cells and Development|November 19, 2010
Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesisHelen Wheadon, Joanne M Ramsey, Edwina Dobbin, et al.
Obesity Surgery|October 24, 2024
A Meta-Analysis Comparing RYGB with Long Biliopancreatic Limb (BPL) Versus Long Alimentary Limb (AL) in Groups with Equal or Nearly Equal Combined Bypass Lengths (Combined BPL and AL Lengths): Does Switching Seats Enhance Weight Loss?Abdul-Rahman F Diab, Joseph A Sujka, Angelica McCaskey, et al.
The International Journal on Drug Policy|March 21, 2021
A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prisonAnna Palmer, Timothy Papaluca, Mark Stoové, et al.
Oncotarget|October 6, 2017
Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapyJodie F Hay, Katrina Lappin, Fabio Liberante, et al.
Journal of Viral Hepatitis|April 21, 2021
Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugsStelliana Goutzamanis, Timothy Spelman, Brendan Harney, et al.
Epidemiology and Infection|May 30, 2025
Legionnaires' disease outbreak linked to a cold-water source in Yorkshire, 2022Alexander Thompson, Aston Quinney, Rob Johnston, et al.
Bioengineering (Basel, Switzerland)|November 10, 2022
Developing Porous Ortho- and Pyrophosphate-Containing Glass Microspheres; Structural and Cytocompatibility CharacterisationBen Milborne, Lauren Murrell, Ian Cardillo-Zallo, et al.
The International Journal on Drug Policy|August 12, 2017
Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascadeNick Scott, Joseph S Doyle, David P Wilson, et al.
F1000Research|August 18, 2020
Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the <i>AAVS1</i> locus as not an entirely safe harbourJamie R Bhagwan, Emma Collins, Diogo Mosqueira, et al.
Pageof 16

Showing results (61-70 of 160) with videos related to

Sort By:
Pageof 16
BMJ Open|September 21, 2023
Quantifying the impact of taking medicines for primary prevention: a time-trade off study to elicit direct treatment disutility in the UKAlexander Thompson, Ji-Hee Youn, Bruce Guthrie, et al.
Stem Cells and Development|November 19, 2010
Differential Hox expression in murine embryonic stem cell models of normal and malignant hematopoiesisHelen Wheadon, Joanne M Ramsey, Edwina Dobbin, et al.
Obesity Surgery|October 24, 2024
A Meta-Analysis Comparing RYGB with Long Biliopancreatic Limb (BPL) Versus Long Alimentary Limb (AL) in Groups with Equal or Nearly Equal Combined Bypass Lengths (Combined BPL and AL Lengths): Does Switching Seats Enhance Weight Loss?Abdul-Rahman F Diab, Joseph A Sujka, Angelica McCaskey, et al.
The International Journal on Drug Policy|March 21, 2021
A costing analysis of a state-wide, nurse-led hepatitis C treatment model in prisonAnna Palmer, Timothy Papaluca, Mark Stoové, et al.
Oncotarget|October 6, 2017
Integrated analysis of the molecular action of Vorinostat identifies epi-sensitised targets for combination therapyJodie F Hay, Katrina Lappin, Fabio Liberante, et al.
Journal of Viral Hepatitis|April 21, 2021
Patient-reported outcomes of the Treatment and Prevention Study: A real-world community-based trial of direct-acting antivirals for hepatitis C among people who inject drugsStelliana Goutzamanis, Timothy Spelman, Brendan Harney, et al.
Epidemiology and Infection|May 30, 2025
Legionnaires' disease outbreak linked to a cold-water source in Yorkshire, 2022Alexander Thompson, Aston Quinney, Rob Johnston, et al.
Bioengineering (Basel, Switzerland)|November 10, 2022
Developing Porous Ortho- and Pyrophosphate-Containing Glass Microspheres; Structural and Cytocompatibility CharacterisationBen Milborne, Lauren Murrell, Ian Cardillo-Zallo, et al.
The International Journal on Drug Policy|August 12, 2017
Reaching hepatitis C virus elimination targets requires health system interventions to enhance the care cascadeNick Scott, Joseph S Doyle, David P Wilson, et al.
F1000Research|August 18, 2020
Variable expression and silencing of CRISPR-Cas9 targeted transgenes identifies the <i>AAVS1</i> locus as not an entirely safe harbourJamie R Bhagwan, Emma Collins, Diogo Mosqueira, et al.
Pageof 16